What is the main purpose of this 8-K filing?

The primary purpose of this 8-K filing is to officially announce and disclose the completion of McKesson Corporation's acquisition of PSS World Medical, Inc., in compliance with SEC regulations.

What is PSS World Medical, Inc. and why would McKesson acquire it?

While this specific 8-K does not detail PSS World Medical's business, it is generally known as a provider of medical supplies and services. McKesson's acquisition of PSS World Medical likely aims to broaden McKesson's product and service offerings, enhance its distribution network, and strengthen its competitive position in the healthcare supply chain.

Where can I find more detailed information about the acquisition?

More detailed information regarding the acquisition, including its terms and potential financial impact, can be found in the press release issued by McKesson Corporation on February 22, 2013, which is attached as Exhibit 99.1 to this 8-K filing.

How does this acquisition affect McKesson's financial statements?

This 8-K filing itself does not contain updated financial statements. However, the acquisition of PSS World Medical, Inc. will be reflected in McKesson's future financial reports, impacting its revenue, assets, liabilities, and earnings, as the financial statements will need to incorporate the results of the acquired company.

MCK 8-K: Regulation FD — Feb 22, 2013

Summary

McKesson Corporation (MCK) has filed an 8-K report on February 22, 2013, to disclose the completion of its acquisition of PSS World Medical, Inc. This strategic move is a significant development for McKesson, likely aimed at expanding its market presence and capabilities within the healthcare sector. Investors should view this acquisition as a key event that could impact the company's future growth trajectory, competitive positioning, and financial performance. The filing primarily serves as a notification of the completed transaction, with the details of the acquisition itself and its financial implications to be found in the accompanying press release. This report underscores McKesson's active approach to strategic growth and consolidation within the pharmaceutical and medical supply distribution industry.

Key Highlights

1McKesson Corporation announced the completion of its acquisition of PSS World Medical, Inc.
2The acquisition was officially reported via an 8-K filing on February 22, 2013.
3The transaction represents a significant strategic move for McKesson.
4This acquisition is expected to impact McKesson's market position and future growth.
5The details of the acquisition are available in an attached press release (Exhibit 99.1).
6The filing serves as a Regulation FD Disclosure and details the completion of a material event.

MCKESSON CORP 8-K Report, Regulation FD Disclosure (Feb 22, 2013)

Summary

Key Highlights

Frequently Asked Questions